MBP Medical Biomaterial Products GmbH
Pharmaceutical Companies · Ludwigslust-Parchim
MBP Medical Biomaterial Products GmbH is a pharmaceutical company based in Ludwigslust-Parchim, Mecklenburg-Vorpommern, Germany. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
MBP Medical Biomaterial Products GmbH – Address & Contact
MBP Medical Biomaterial Products GmbH Overview
MBP Medical Biomaterial Products GmbH is a pharmaceutical company based in Ludwigslust-Parchim, Mecklenburg-Vorpommern. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).
Activities & Products
Pharmaceutical companies such as MBP Medical Biomaterial Products GmbH develop, produce or distribute medicines for the German and international market. All authorised products are subject to approval and are regulated by BfArM or the European Medicines Agency (EMA).
About MBP Medical Biomaterial Products GmbH
Auf der Basis von natürlichem Porcinem Kollagen
Location & Contact
MBP Medical Biomaterial Products GmbH can be reached at the following address: Lederstr. 7, 19306 Ludwigslust-Parchim – Phone: 0387575090. For current information and enquiries, please contact the company directly.
More information: Pharmaunternehmen in Mecklenburg-Vorpommern or all Pharmaunternehmen in Germany on Sanoliste.
Pharmazeutische Regulierung in Deutschland
Pharmaceutical companies such as MBP Medical Biomaterial Products GmbH are subject to one of the world's most stringent regulatory frameworks in Germany. The German Medicinal Products Act (AMG) governs the authorisation, manufacturing, distribution and monitoring of medicinal products. Market authorisation for new active substances falls under the responsibility of either the Federal Institute for Drugs and Medical Devices (BfArM) or the European Medicines Agency (EMA), depending on whether a national or centralised authorisation is sought.
Arzneimittelversorgung & Marktumfeld
With a revenue volume exceeding 50 billion euros, the German pharmaceutical market is one of the largest in Europe. MBP Medical Biomaterial Products GmbH, based in Ludwigslust-Parchim, is part of this market. The supply chain from manufacturer through wholesaler to pharmacy is governed by Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP). Since the entry into force of the Act for Greater Safety in the Medicinal Products Supply (GSAV), stricter requirements for the traceability of medicinal products also apply.
Pharmastandort Mecklenburg-Vorpommern
Mecklenburg-Vorpommern is a significant pharmaceutical location in Germany. Companies such as MBP Medical Biomaterial Products GmbH benefit from proximity to research institutions, university hospitals and well-developed infrastructure. The industry employs over 140,000 people in Germany and invests billions annually in research and development.
Frequently asked questions about MBP Medical Biomaterial Products GmbH
What does MBP Medical Biomaterial Products GmbH do?
MBP Medical Biomaterial Products GmbH produces and disributes medical devices on the Basis of natürlichem Kollagen. Anwendungsgebiete are Hämostase, Wandbehandlung and Geweberegeneration. Zum Sortiment gehören MB-Loops for the Kennzeichnen of Arterien, Venen and Nerven. Auf dem Gebiet the Kollagenverarattung gilt the company withtlerweile als internationaler Experte.
What medicines does MBP Medical Biomaterial Products GmbH manufacture?
MBP Medical Biomaterial Products GmbH is a pharmaceutical company in Ludwigslust-Parchim. Überblick Die MBP Medical Biomaterial Products GmbH is ein führendes company in the manufacturing and Vermarktung of medizinischen Biomaterialien and Implantaten. Mit Sitz in Alle in Germany zugelassenen medicines are in the medicines-Datenbank des BfArM recherchierbar.
How are medicines approved in Germany?
Neue medicines benötigen vor dem Inverkehrbringen eine Zulassung durch the BfArM (national) or the EMA (europaweit). Der Zulassungsprozess umfasst the Prüfung of quality, Wirksamkeit and Unbedenklichkeit on Basis präklinischer and klinischer Stuthen. Die Nutzenbewertung after § 35a SGB V entscheidet about the Erstattung durch the gesetzlichen Krankenkassen.
What does GMP mean in pharmaceutical production?
GMP (Good Manufacturing Practice) bezeichnet the Gute manufacturingspraxis – ein System of qualitysstandards, the sicherstellt, thes medicines gleichbleibend after den gefortheten qualitysnormen hergestellt and geprüft are. Die GMP-Richtlinien are in the EU durch den EudraLex Volume 4 definiert.
Pharmaceutical Companies in Germany
Related areas in healthcare
Pharmaceutical Companies in Mecklenburg-Vorpommern
All Pharmaceutical Companies in Mecklenburg-Vorpommern on Sanoliste — or discover all categories by federal state.